Skip to content

The Role of Hydrosalpinx in Recurrent Miscarriage

The Role of Hydrosalpinx in Recurrent Miscarriage

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03703401
Enrollment
137
Registered
2018-10-12
Start date
2018-02-28
Completion date
2021-01-15
Last updated
2022-11-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abortion, Spontaneous, Hydrosalpinx, Miscarriage, Recurrent

Brief summary

Miscarriage affects one in five pregnancies and little progress has been made in understanding and treating this distressing condition. C. trachomatis is the most common sexually transmitted infection in the UK. C. trachomatis infection can have serious health consequences, including fallopian tube damage. Untreated C. trachomatis infection and tubal damage have been associated with miscarriage and adverse pregnancy outcomes such as preterm birth, low birth weight and stillbirth. A cohort study is needed to establish the prevalence of tubal disease in women with recurrent miscarriages. HyCoSy will be performed to identify tubal disease and establish the magnitude of the problem in the recurrent miscarriage population. The prognosis of tubal disease on miscarriage and other obstetric outcomes, and the role of medical interventions such as tubal surgery (to treat hydrosalpinx) on reducing miscarriage and adverse obstetric outcomes will also be studied. Objectives 1. Establish the prevalence of hydrosalpinx in the recurrent miscarriage population. 2. Establish the prognosis of women diagnosed with recurrent miscarriage with concurrent hydrosalpinx. 3. Explore the role of tubal surgery for improving reproductive outcomes in women with recurrent miscarriage population and hydrosalpinx.

Interventions

DIAGNOSTIC_TESTHysterosalpingo-contrast-sonogram

A contrast ultrasound scan to examine fallopian tube pathology and blockage

Sponsors

Tommy's
CollaboratorOTHER
University of Birmingham
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Age 18-45 * Women diagnosed with recurrent miscarriage i.e. 2 or more miscarriages * Ability to give informed consent

Exclusion criteria

* Allergy to contrast media used for Hysterosalpingo-contrast-sonogram * Allergy to sonographic gel used for ultrasound scanning * Anatomical anomaly meaning transvaginal ultrasound scan not possible * Stenosed/occluded cervix meaning contrast media unable to be introduced via cervix * Inability to give informed consent * Pregnant at the time of recruitment * Declined recruitment

Design outcomes

Primary

MeasureTime frameDescription
Hydrosalpinx12 monthsThe presence or absence of tubal blockage and hydrosalpinx

Secondary

MeasureTime frameDescription
Miscarriage12 monthsThe loss of a pregnancy below 24 completed week of gestation

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026